Io Therapeutics, Inc
USPTO PatentsView assignee record - 71 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Io ranks #4,889 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 10 technology areas.
- #4,889
- of 49,997 US assignees by volume
- Top 35%
- by Innovation Score (40.6/100)
- 19.0
- avg claims per patent
- +145%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4889 · US Corporation #4,889 · 71 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 71 grants
- TOP-DECILE #4,889/49,997
- PHOTO-FINISH Hyperfine Research
- CPC-FOCUS A61K · 10 areas
- INNOV-PAR 40.6/100
- CLAIMS-RICH 19.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +145% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Hyperfine Research, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Io’s 40.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Io
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Actelion Pharmaceuti… · near
Actelion Pharmaceuti… · near
41 score
- Io Therapeutics · this assignee
Io Therapeutics · this assignee
41 score
- K4connect · near
K4connect · near
41 score
- Kyowa Kirin · near
Kyowa Kirin · near
41 score
- Mbda Deutschland · near
Mbda Deutschland · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Io's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Io?
Each dot is one of Io’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Io’s own 19.0 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Io's grants concentrate
Io Therapeutics, Inc is a focused PatentsView assignee: 10 CPC subclasses with 97.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (16 grants) versus a trough of 2 in 2016. By volume, Io sits between Hyperfine Research, Inc. and LS Cable & System Ltd..
Io's three-year grant acceleration
From 2019–2021 to 2022–2024, Io Therapeutics, Inc moved from 39 to 19 grants (0.49x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Io's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hyperfine Research
Hyperfine Research, Inc.
71 patents
- Innoplexus
Innoplexus AG
71 patents
- International Rec…
International Rectifier Corporation
71 patents
- Inventus Holdings
Inventus Holdings, LLC
71 patents
- Kikkoman
Kikkoman Corporation
71 patents
- Klein Tools
Klein Tools, Inc.
71 patents
- L&L Candle
L&L Candle Company, LLC
71 patents
- LS Cable & System
LS Cable & System Ltd.
71 patents
- Io Therapeutics ◀
Io Therapeutics, Inc
71 patents
What this shows Io holds 71 patents at rank #4,889, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Io
By rank, the assignees closest to #4,889 in granted patent volume.
- Hyperfine Research, Inc. #4,885 · 71 patents
- Innoplexus AG #4,886 · 71 patents
- International Rectifier Corporation #4,887 · 71 patents
- Inventus Holdings, LLC #4,888 · 71 patents
- Kikkoman Corporation #4,890 · 71 patents
- Klein Tools, Inc. #4,891 · 71 patents
- L&L Candle Company, LLC #4,892 · 71 patents
- LS Cable & System Ltd. #4,893 · 71 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Io's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Io, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Io ranks #287 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Similar claim depth
Nearest assignees by average claims per patent (19.0 here).
Io's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 2.8% |
| 2017 | 2 | 2.8% |
| 2018 | 7 | 9.9% |
| 2019 | 9 | 12.7% |
| 2020 | 16 | 22.5% |
| 2021 | 14 | 19.7% |
| 2022 | 3 | 4.2% |
| 2023 | 11 | 15.5% |
| 2024 | 5 | 7.0% |
| 2025partial year | 2 | 2.8% |
Which technologies does Io Therapeutics, Inc patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Io Therapeutics, Inc's patent record in context - here's where to go next.
- Io Therapeutics, Inc's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.2% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #4,889 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Io Therapeutics, Inc against Hyperfine Research, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.